Market cap
$235 Mln
Revenue (TTM)
$906 Mln
P/E Ratio
--
P/B Ratio
0.5
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -7.79 | -3.64 | -0.78 | -0.81 | -5.94 |
| EBIT | 95.95 | -141.56 | -99.30 | -84.92 | -71.87 |
| Net Profit | 62.49 | 12.94 | -190.46 | -162.79 | -164.20 |
| EPS | 74.03 | 15.76 | -228.50 | -171.83 | -170.57 |
| Book Value | -- | -- | 4.58 | 8.90 | 6.92 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| 8.23 | 9.96 | 0.04 | 4.58 | 8.97 |
| Net Margin
| -- | 9.82 | -2.34 | -- | -- |
| Return on equity
| 7.96 | 13.69 | -2.77 | 2.02 | 8.17 |
| Return on Capital
| 7.67 | 13.15 | -- | 1.92 | 7.77 |
| Return on Assets
| 5.97 | 9.77 | -2.30 | 1.44 | 6.09 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.03 | 0.07 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
--
|
1.92
|
7.77
|
13.31
|
16.12
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-2.77
Lower than Peers by 12.59
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
-2.77
|
2.02
|
8.17
|
13.69
|
16.72
|
|
Peer Median
|
9.82
|
--
|
--
|
--
|
--
|
ROA
-2.30
Lower than Peers by 5.96
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
-2.30
|
1.44
|
6.09
|
10.38
|
11.81
|
|
Peer Median
|
3.66
|
--
|
--
|
--
|
--
|
EBIT Margin
0.04
Lower than Peers by 8.76
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
0.04
|
4.58
|
8.97
|
11.15
|
10.78
|
|
Peer Median
|
8.80
|
--
|
--
|
--
|
--
|
Net Margin
-2.34
Lower than Peers by 7.58
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
-2.34
|
1.16
|
4.92
|
6.93
|
6.94
|
|
Peer Median
|
5.24
|
--
|
--
|
--
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-0.78
Lower than Peers by 1.59
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
-0.78
|
0.08
|
-0.07
|
-0.08
|
-0.16
|
|
Peer Median
|
0.81
|
--
|
--
|
--
|
--
|
EBIT Growth
-99.30
Lower than Peers by 97.59
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
-99.30
|
-44.71
|
-25.39
|
-4.55
|
-36.77
|
|
Peer Median
|
-1.72
|
--
|
--
|
--
|
--
|
Net Profit Growth
-190.46
Lower than Peers by 187.91
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
-190.46
|
-74.40
|
-34.11
|
-8.02
|
-40.47
|
|
Peer Median
|
-2.55
|
--
|
--
|
--
|
--
|
EPS Growth
-228.50
Lower than Peers by 251.20
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
-228.50
|
-0.73
|
-0.34
|
-0.08
|
-0.39
|
|
Peer Median
|
22.70
|
--
|
--
|
--
|
--
|
Book Value Growth
-1.35
Lower than Peers by 9.66
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
-1.35
|
--
|
--
|
--
|
--
|
|
Peer Median
|
8.30
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
--
|
0.03
|
0.07
|
0.03
|
0.03
|
|
Peer Median
|
0.59
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
--
|
0.03
|
0.05
|
0.02
|
0.02
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.59
Higher than Peers by 0.91
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
2.59
|
2.24
|
2.00
|
3.52
|
2.65
|
|
Peer Median
|
1.68
|
--
|
--
|
--
|
--
|
Quick Ratio
1.84
Higher than Peers by 0.96
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
1.84
|
1.45
|
1.50
|
3.00
|
2.18
|
|
Peer Median
|
0.88
|
--
|
--
|
--
|
--
|
Interest Coverage
0.85
Lower than Peers by 3.74
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
0.85
|
50.32
|
272.71
|
392.04
|
560.49
|
|
Peer Median
|
4.59
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
0.56
Lower than Peers by 8.45
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
0.56
|
--
|
0.96
|
0.78
|
0.72
|
|
Peer Median
|
9.01
|
--
|
--
|
--
|
--
|
Asset Turnover
0.98
Higher than Peers by 0.35
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
0.98
|
1.24
|
1.24
|
1.50
|
1.70
|
|
Peer Median
|
0.64
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
--
|
3.25
|
3.30
|
2.86
|
2.63
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
--
|
156.70
|
136.32
|
123.95
|
155.80
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
--
|
26.59
|
22.92
|
20.36
|
23.13
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
--
|
133.36
|
116.70
|
106.44
|
135.30
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
--
|
33.39
|
16.31
|
16.18
|
14.78
|
|
Peer Median
|
20.99
|
--
|
--
|
--
|
--
|
Price / Book Value
0.45
Lower than Peers by 1.24
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
0.45
|
0.67
|
1.29
|
2.08
|
2.36
|
|
Peer Median
|
1.69
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
2.73
|
--
|
--
|
--
|
--
|
EV/EBITDA
2.12
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
2.12
|
2.62
|
5.49
|
5.81
|
5.81
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
235
Lower than Peers by 445
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
USANA Health Sciences (USNA)
|
235
|
--
|
--
|
--
|
--
|
|
Peer Median
|
681
|
--
|
--
|
--
|
--
|